JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production

Timothy P. Labranche, Michael I. Jesson, Zaher A. Radi, Chad E. Storer, Julia A. Guzova, Sheri L. Bonar, Janice M. Thompson, Fernando A. Happa, Zachary S. Stewart, Yutian Zhan, Chris S. Bollinger, Prashant N. Bansal, Jeremy W. Wellen, Dean P. Wilkie, Steven A. Bailey, Peter T. Symanowicz, Martin Hegen, Richard D. Head, Nandini Kishore, Gabriel MbalavieleDebra M. Meyer

Research output: Contribution to journalArticlepeer-review

98 Scopus citations

Fingerprint

Dive into the research topics of 'JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production'. Together they form a unique fingerprint.

Medicine & Life Sciences